NBIX
Neurocrine Biosciences, Inc.Healthcare$131.60
▼ Bearish
Mkt Cap: $13.21B|Float: 99.1M|SI: 3.9%|DTC: 3.6
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
21.8%
52W Range
$84-$160
ATR(14)
$3.48
Exp. Move
±5.7%
P/C Ratio
1.51
Earnings
May 4
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
NBIX Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $0.4M
- Max Pain
- $130.00
- Expected Move
- ±5.7%
- Put/Call OI
- 1.51
- Net Premium
- $-2.1M
- Spot Price
- $131.60
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$7.55 | ±5.7% | $124.05 | $139.15 |
| 2026-05-15 | 43 | ±$15.65 | ±11.9% | $115.95 | $147.25 |
| 2026-06-18 | 77 | ±$20.25 | ±15.4% | $111.35 | $151.85 |
| 2026-08-21 | 141 | ±$15.00 | ±11.4% | $116.60 | $146.60 |
| 2026-12-18 | 260 | ±$35.25 | ±26.8% | $96.35 | $166.85 |
| 2027-01-15 | 288 | ±$17.00 | ±12.9% | $114.60 | $148.60 |
Explore NBIX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.